Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Metadata
Title
Human herpesvirus 6 and human herpesvirus 7: Emerging pathogens in transplant patients
Author
Duncan A. Clark
Publication date
01-03-2002
Publisher
Springer-Verlag
Published in
International Journal of Hematology / Issue Special Issue 2/2002
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF03165124

Other articles of this Special Issue 2/2002

International Journal of Hematology 2/2002 Go to the issue

Hematomorphology

The diagnosis from the pathological viewpoint of a blood disease

Role of Blood and Marrow Nurses in Field of Transplants

Research within the field of blood and marrow transplantation nursing: How can it contribute to higher quality of care?

Role of Blood and Marrow Nurses in Field of Transplants

The present state of advanced practice nursing in hematopoietic stem cell transplantation field in Korea

Thalassemia and Hemoglobinopathy

β-Thalassaemia prototype of a single gene disorder with multiple phenotypes

Treatment of Childhood Malignancy

Designer drugs: New directed therapies for cancer

Cytogenetics

Genetics of childhood acute lymphoblastic leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits